Efficacy and safety of edaravone dexborneol in acute ischemic stroke: systematic review and meta-analysis
BackgroundEdaravone dexborneol represents a novel neuroprotective agent utilized in the treatment of acute ischemic stroke (AIS). Preliminary studies indicate that this combination exhibits enhanced therapeutic effects when compared to the use of edaravone alone. The objective of this study was to a...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2025-10-01
|
| Edice: | Frontiers in Neurology |
| Témata: | |
| On-line přístup: | https://www.frontiersin.org/articles/10.3389/fneur.2025.1649476/full |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|